Literature DB >> 19308469

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Ignacio F Mata1, Carolyn M Hutter, María C González-Fernández, Marian M de Pancorbo, Elena Lezcano, Cecilia Huerta, Marta Blazquez, Renee Ribacoba, Luis M Guisasola, Carlos Salvador, Juan C Gómez-Esteban, Juan J Zarranz, Jon Infante, Joseph Jankovic, Hao Deng, Karen L Edwards, Victoria Alvarez, Cyrus P Zabetian.   

Abstract

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene together represent the most common genetic determinant of Parkinson's disease (PD) identified to date. The vast majority of patients with LRRK2-related PD reported in the literature carry one of three pathogenic substitutions: G2019S, R1441C, or R1441G. While G2019S and R1441C are geographically widespread, R1441G is most prevalent in the Basque Country and is rare outside of Northern Spain. We sought to better understand the processes that have shaped the current distribution of R1441G. We performed a haplotype analysis of 29 unrelated PD patients heterozygous for R1441G and 85 wild-type controls using 20 markers that spanned 15.1 Mb across the LRRK2 region. Nine of the patients were of Basque origin and 20 were non-Basques. We inferred haplotypes using a Bayesian approach and utilized a maximum-likelihood method to estimate the age of the most recent common ancestor. Significant but incomplete allele sharing was observed over a distance of 6.0 Mb and a single, rare ten-marker haplotype 5.8 Mb in length was seen in all mutation carriers. We estimate that the most recent common ancestor lived 1,350 (95% CI, 1,020-1,740) years ago in approximately the seventh century. We hypothesize that R1441G originated in the Basque population and that dispersion of the mutation then occurred through short-range gene flow that was largely limited to nearby regions in Spain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19308469      PMCID: PMC2821036          DOI: 10.1007/s10048-009-0187-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  44 in total

1.  A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.

Authors:  C P Zabetian; A Samii; A D Mosley; J W Roberts; B C Leis; D Yearout; W H Raskind; A Griffith
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Authors:  Daniela Berg; Katherine J Schweitzer; Petra Leitner; Alexander Zimprich; Peter Lichtner; Petra Belcredi; Theresa Brüssel; Claudia Schulte; Sylvia Maass; Thomas Nägele; Zbigniew K Wszolek; Thomas Gasser
Journal:  Brain       Date:  2005-12       Impact factor: 13.501

3.  Allelic frequencies of 13 STR loci in autochthonous Basques from the province of Vizcaya (Spain).

Authors:  A M Pérez-Miranda; M A Alfonso-Sánchez; A Kalantar; J A Peña; M M de Pancorbo; R J Herrera
Journal:  Forensic Sci Int       Date:  2004-12-10       Impact factor: 2.395

4.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.

Authors:  Suzanne Lesage; Alexandra Dürr; Meriem Tazir; Ebba Lohmann; Anne-Louise Leutenegger; Sabine Janin; Pierre Pollak; Alexis Brice
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

5.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Laurie J Ozelius; Geetha Senthil; Rachel Saunders-Pullman; Erin Ohmann; Amanda Deligtisch; Michele Tagliati; Ann L Hunt; Christine Klein; Brian Henick; Susan M Hailpern; Richard B Lipton; Jeannie Soto-Valencia; Neil Risch; Susan B Bressman
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

Review 6.  Genetics of Parkinson disease: paradigm shifts and future prospects.

Authors:  Matthew James Farrer
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

7.  Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.

Authors:  Denise M Kay; Cyrus P Zabetian; Stewart A Factor; John G Nutt; Ali Samii; Alida Griffith; Tom D Bird; Patricia Kramer; Donald S Higgins; Haydeh Payami
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

8.  LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Authors:  Carles Gaig; Mario Ezquerra; Maria Jose Marti; Esteban Muñoz; Francesc Valldeoriola; Eduardo Tolosa
Journal:  Arch Neurol       Date:  2006-03

9.  The mitochondrial lineage U8a reveals a Paleolithic settlement in the Basque country.

Authors:  Ana M González; Oscar García; José M Larruga; Vicente M Cabrera
Journal:  BMC Genomics       Date:  2006-05-23       Impact factor: 3.969

10.  The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.

Authors:  S Goldwurm; A Di Fonzo; E J Simons; C F Rohé; M Zini; M Canesi; S Tesei; A Zecchinelli; A Antonini; C Mariani; N Meucci; G Sacilotto; F Sironi; G Salani; J Ferreira; H F Chien; E Fabrizio; N Vanacore; A Dalla Libera; F Stocchi; C Diroma; P Lamberti; C Sampaio; G Meco; E Barbosa; A M Bertoli-Avella; G J Breedveld; B A Oostra; G Pezzoli; V Bonifati
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

View more
  11 in total

1.  Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2.

Authors:  Xiaojie Li; Darren J Moore; Yulan Xiong; Ted M Dawson; Valina L Dawson
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

2.  Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.

Authors:  Md Shariful Islam; Hendrik Nolte; Wright Jacob; Anna B Ziegler; Stefanie Pütz; Yael Grosjean; Karolina Szczepanowska; Aleksandra Trifunovic; Thomas Braun; Hermann Heumann; Rolf Heumann; Bernhard Hovemann; Darren J Moore; Marcus Krüger
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

3.  The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot.

Authors:  Ignacio F Mata; Marie Y Davis; Alexis N Lopez; Michael O Dorschner; Erica Martinez; Dora Yearout; Brenna A Cholerton; Shu-Ching Hu; Karen L Edwards; Thomas D Bird; Cyrus P Zabetian
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-04-25       Impact factor: 3.568

4.  Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

Authors:  Taku Hatano; Manabu Funayama; Shin-Ichiro Kubo; Ignacio F Mata; Yutaka Oji; Akio Mori; Cyrus P Zabetian; Sarah M Waldherr; Hiroyo Yoshino; Genko Oyama; Yasushi Shimo; Ken-Ichi Fujimoto; Hirokazu Oshima; Yasuto Kunii; Hirooki Yabe; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Neurobiol Aging       Date:  2014-06-02       Impact factor: 4.673

5.  Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort.

Authors:  Nicole Bryant; Nicole Malpeli; Julia Ziaee; Cornelis Blauwendraat; Zhiyong Liu; Andrew B West
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

Review 6.  Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Authors:  Iakov N Rudenko; Ruth Chia; Mark R Cookson
Journal:  BMC Med       Date:  2012-02-23       Impact factor: 8.775

7.  Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Authors:  Mario Cornejo-Olivas; Luis Torres; Mario R Velit-Salazar; Miguel Inca-Martinez; Pilar Mazzetti; Carlos Cosentino; Federico Micheli; Claudia Perandones; Elena Dieguez; Victor Raggio; Vitor Tumas; Vanderci Borges; Henrique B Ferraz; Carlos R M Rieder; Artur Shumacher-Schuh; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Francisco Lopera; Jorge Chang-Castello; Brennie Andreé-Munoz; Sarah Waldherr; Dora Yearout; Cyrus P Zabetian; Ignacio F Mata
Journal:  NPJ Parkinsons Dis       Date:  2017-06-02

8.  Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.

Authors:  Nadège Calmels; Géraldine Greff; Cathy Obringer; Nadine Kempf; Claire Gasnier; Julien Tarabeux; Marguerite Miguet; Geneviève Baujat; Didier Bessis; Patricia Bretones; Anne Cavau; Béatrice Digeon; Martine Doco-Fenzy; Bérénice Doray; François Feillet; Jesus Gardeazabal; Blanca Gener; Sophie Julia; Isabel Llano-Rivas; Artur Mazur; Caroline Michot; Florence Renaldo-Robin; Massimiliano Rossi; Pascal Sabouraud; Boris Keren; Christel Depienne; Jean Muller; Jean-Louis Mandel; Vincent Laugel
Journal:  Orphanet J Rare Dis       Date:  2016-03-22       Impact factor: 4.123

9.  Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.

Authors:  Carlo Alberto Artusi; Alok K Dwivedi; Alberto Romagnolo; Gian Pal; Marcelo Kauffman; Ignacio Mata; Dhiren Patel; Joaquin A Vizcarra; Andrew Duker; Luca Marsili; Binith Cheeran; Daniel Woo; Maria Fiorella Contarino; Leonard Verhagen; Leonardo Lopiano; Alberto J Espay; Alfonso Fasano; Aristide Merola
Journal:  JAMA Netw Open       Date:  2019-02-01

10.  R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.

Authors:  Ying Fan; Raja S Nirujogi; Alicia Garrido; Javier Ruiz-Martínez; Alberto Bergareche-Yarza; Elisabet Mondragón-Rezola; Ana Vinagre-Aragón; Ioana Croitoru; Ana Gorostidi Pagola; Laura Paternain Markinez; Roy Alcalay; Richard A Hickman; Jonas Düring; Sara Gomes; Neringa Pratuseviciute; Shalini Padmanabhan; Francesc Valldeoriola; Leticia Pérez Sisqués; Cristina Malagelada; Teresa Ximelis; Laura Molina Porcel; Maria José Martí; Eduardo Tolosa; Dario R Alessi; Esther M Sammler
Journal:  Acta Neuropathol       Date:  2021-06-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.